NEWS
Science is moving fast—
and so we are
Press
What we’ve been up to.
From product milestones to scientific insights and company updates, here’s a look at what’s happening inside (and around) Arpelos.
Subscribe for updates
Categories
Please select categories you are interested in.
Corporate
Events
Press
Research
Team
Updates
Corporate
January 7, 2025
Platform update enables multi-compound parallel testing
Our latest release introduces faster, multiplexed compound screening—making it easier for partners to compare variants in a single run.
Read more
Team
January 13, 2025
Arpelos joins panel on translational immunology at BioMedX
CSO Lina Kovach will discuss how ex vivo blood profiling is reshaping how we understand early immune responses to drug candidates.
Read more
Corporate
January 7, 2025
Internship program launches for
early-career scientists
We’re proud to announce new backing from top-tier biotech investors to expand our team, scale operations, and bring our cell-level insights to more pharma partners.
Read more
Team
January 7, 2025
Pilot study launched with top-10 pharma company
We’ve kicked off a collaborative study focused on mapping immune cell responses to early-stage oncology candidates. Results expected later this year.
Read more
Press
December 27, 2024
Arpelos featured in Nature Biotechnology startup spotlight
Our work was highlighted for its novel approach to understanding how therapies impact blood cell populations—bridging discovery and clinical translation.
Read more
Research
December 15, 2024
New dataset released: Single-cell profiles across 30 donors
We’ve published anonymized data from a large-scale screen exploring immune responses to targeted therapies—now available for academic and industry collaborators.
Read more
